Skip to main content

Affymetrix Partners with Navigenics to Offer Personal Genetics Service

NEW YORK (GenomeWeb News) - Affymetrix and personal genetics startup Navigenics are teaming up to provide consumers with an understanding of their genetic predisposition for developing certain medical conditions.
 
Under that pact, which Affymetrix President Kevin King disclosed this week at the UBS Global Life Sciences Conference in New York, consumers will be able to go to the Navigenics website and order a saliva collection kit. The customer will then send the kit to Affymetrix’s CLIA lab, which will run a whole-genome screen and send the analysis to Navigenics. Then, Navigenics will provide the genetic-predisposition analysis to the customer via a secure, private web portal and offer genetic counseling.
 
Neither Affymetrix nor Navigenics, which has been funded by venture capital firms Kleiner Perkins and Sequoia Capital, has disclosed the cost of the service or its launch date, but Affymetrix officials said the firm is “realistic” and does not expect the alliance to provide it any significant revenue in the near term.
 
King added that the potential of combining electronic health records with the personal genetics service could eventually help healthcare providers and researchers better understand the role that environmental factors play in disease.
 
Navigenics is offering a similar service to that of another consumer genotyping startup, 23andMe. GenomeWeb Daily News sister publication BioArray News reported last month that Illumina had inked a partnership with 23andMe under which it would provide the company customized SNP arrays.
 
News of the alliance between Affymetrix and Navigenics was first reported in yesterday's issue of GenomeWeb Daily News sister publication BioCommerce Week.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.